Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Mar;23(1):48-62.
doi: 10.1007/s11065-013-9227-4. Epub 2013 Feb 12.

Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy

Affiliations
Review

Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy

Jimmy Choi et al. Neuropsychol Rev. 2013 Mar.

Abstract

Cognitive rehabilitation therapies for Alzheimer's disease (AD) are becoming more readily available to the geriatric population in an attempt to curb the insidious decline in cognitive and functional performance. However, people with AD may have difficulty adhering to these cognitive treatments due to denial of memory deficits, compromised brain systems, cognitive incapacity for self-awareness, general difficulty following through on daily tasks, lack of motivation, hopelessness, and apathy, all of which may be either due to the illness or be secondary to depression. Cognitive rehabilitation training exercises are also labor intensive and, unfortunately, serve as a repeated reminder about the memory impairments and attendant functional consequences. In order for cognitive rehabilitation methods to be effective, patients must be adequately engaged and motivated to not only begin a rehabilitation program but also to remain involved in the intervention until a therapeutic dosage can be attained. We review approaches to cognitive rehabilitation in AD, neuropsychological as well as psychological obstacles to effective treatment in this population, and methods that target adherence to treatment and may therefore be applicable to cognitive rehabilitation therapies for AD. The goal is to stimulate discussion among researchers and clinicians alike on how treatment effects may be mediated by engagement in treatment, and what can be done to enhance patient adherence for cognitive rehabilitation therapies in order to obtain greater cognitive and functional benefits from the treatment itself.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Putative determinants of cognitive enhancing therapy outcome in Alzheimer’s disease

References

    1. Alexopoulos G, Abrams R, Young R, Shamoian C. Cornell Scale for Depression in Dementia. Biological Psychiatry. 1988a;23:271–284. - PubMed
    1. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biological Psychiatry. 1988b;23:271–284. - PubMed
    1. Amanzio M, Torta DME, Sacco K, Cauda F, D’Agata F, Duca S, Leotta D, Palermo S, Geminiani GC. Unawareness of deficits in Alzheimer’s disease: role of the cingulate cortex. Brain. 2011;134:1061–1076. - PubMed
    1. Avila R, Bottino CMC, Carvalho IAM, Santos CB, Seral C, Miotto EC. Neuropsychological rehabilitation of memory deficits and activities of daily living in patients with Alzheimer's disease: a pilot study. Brazilian Journal of Medical and Biological Research. 2004;37:1721–1729. - PubMed
    1. Ball K, Berch DB, Helmers KF, et al. Effects of cognitive training interventions with older adults: A randomized controlled trial. JAMA. 2002;288:2271–2281. - PMC - PubMed

Publication types